ALIGNMT AI, a leading AI compliance platform for healthcare, today announced $6.5 million in seed funding led by AIX Ventures, with participation from Sancus Ventures, Alumni Ventures and Dent Capital. The funding will accelerate the company's mission to build trust in AI products through comprehensive, real-time governance that ensures every AI system operates safely, transparently, and equitably.
The Compliance Crisis in AI
Healthcare organizations are increasingly leveraging AI to improve patient outcomes, yet many lack the governance frameworks needed to monitor model behavior, enforce zero-trust safeguards, and maintain regulatory compliance. Meanwhile, new rules, ranging from Coalition for Health AI (CHAI) transparency standards to the EU AI Act, mandate ongoing risk assessments, documentation, and reporting that most organizations aren't equipped to handle. Without a unified platform to surface emerging AI vulnerabilities, automate safeguards, and generate audit-ready reports, companies face not only compliance fines but also erosion of stakeholder trust and potential harm to the very people they serve.
ALIGNMT's Unified Platform for AI Risk Mitigation
ALIGNMT AI delivers the executive-level AI oversight that healthcare leaders demand: comprehensive risk mitigation through a governance-first platform that continuously monitors AI systems without exposing sensitive patient data. This automated solution eliminates fragmented manual compliance processes, providing real-time risk detection and streamlined alignment with CHAI, ONC HTI-1, DOJ, and EU AI Act requirements. The outcome is proactive risk management that cuts compliance time in half, prevents costly penalties, and enables confident AI scaling across the enterprise.
“Healthcare leaders are recognizing that AI governance is no longer optional, it's critical infrastructure that must layer seamlessly onto existing production workflows to enable real-time risk monitoring,” said Andreea Bodnari, CEO of ALIGNMT AI. “This funding allows us to accelerate our platform development and expand our partnerships with leading healthcare institutions.”
The company is already working with major health systems, payers, and health IT companies like electronic medical record platforms and AI developers. ALIGNMT AI's work leading the industry towards AI assurance has gained significant recognition and is the focus of a case study being prepared by Harvard Business School for winter 2025.
“ALIGNMT.AI is the transformative solution hospitals and healthcare systems have been waiting for as they scale AI,” said Krish Ramadurai, Partner at AIX Ventures and lead investor in their seed round. “It gives clinical and compliance teams real-time visibility into every AI tool they deploy, surfacing issues instantly and helping them avoid costly mistakes. We're already seeing healthcare providers cut compliance prep time by half, enabling them to confidently roll out new AI solutions that improve patient care safely and effectively.”
The seed funding will enable ALIGNMT AI to expand its engineering team, accelerate product development, and scale partnerships with healthcare organizations seeking to deploy AI responsibly while maintaining operational efficiency and patient safety.
Healthcare organizations can learn more at https://alignmt.ai/.
About ALIGNMT AI
ALIGNMT AI provides comprehensive AI governance and risk management solutions that safeguard artificial intelligence across its entire lifecycle. The platform automates compliance workflows, continuous risk monitoring, and transparency reporting, transforming fragmented processes into a unified, scalable system. Certified by the Coalition for Healthcare AI and trusted by leading healthcare institutions, ALIGNMT AI helps organizations deploy AI responsibly while maintaining operational efficiency and patient safety. Learn more or request a demo at alignmt.ai.
— WebWireID343081 —
